Sabra Health Care REIT (SBRA)
NASDAQReal EstateReit - Healthcare FacilitiesSnapshot 2026-09-04
$20.78-0.72%
Close 2026-09-04 · 1-day change
NASDAQReal EstateReit - Healthcare FacilitiesSnapshot 2026-09-04
QuarterlyIQ Insights · SBRA
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How this business ranks within real estate on a research-validated quality screen. As of 2026-09-04.
The screen ranks SBRA against its sector on four durable signals: share dilution, return on capital, free-cash-flow yield, and FCF margin. Historically the highest-quality names tended toward better typical outcomes and fewer bad years over multi-year holds (strongest at three years, modest at one), and that pattern showed up even before the price moved. It characterizes business quality, not price direction.
Each leg is a sector-relative percentile (higher is better); 2 of 4 legs were available for this name. The composite is built from these four; the raw value follows each percentile for context.
A forward quality tilt, not a price prediction, and context for your own research rather than a recommendation. Not investment advice.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Real Estate names rated strong grew net income 57% of the time over the next year (vs 53% for the rest of the cohort, n=2778).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Maintain and raise full-year 2026 earnings guidance reflecting operational performance and portfolio initiatives.
Stated as a priority in 4 quarters including a July 2026 business update. Management reiterated and increased full-year 2026 guidance, expecting Normalized FFO and AFFO per share to grow 7% and 8% over 2025. This aligns with operational performance and portfolio initiatives, indicating delivery on earnings growth guidance.
“Sabra is also reiterating its full year 2026 guidance, which was included in Sabra's July 21, 2026, business update.”
“We are reiterating our full-year guidance.”
“Sabra is initiating 2026 earnings guidance ranges as follows (attributable to Sabra Health Care REIT, Inc., per diluted common share): Net Income: $0.60 - $0.64”
Continue paying a quarterly cash dividend of $0.30 per share to common stockholders.
Management stated the $0.30 quarterly dividend in 5 consecutive quarters from 2025-Q2 through 2026-Q2. The dividend per share remained steady at $0.30, demonstrating consistent capital return to shareholders and delivery on this capital allocation priority.
“On August 3, 2026, Sabra's Board of Directors declared a quarterly cash dividend of $0.30 per share.”
Grow revenue and expand portfolio through acquisitions and investments in senior housing and skilled nursing properties.
Management stated this priority in 3 quarters including 2026-Q1 and Q2. Revenue increased from $183.5M in 2025-Q1 to $221.8M in 2026-Q1. Investments closed grew from $206.1M in 2026-Q1 to $599M by 2026-Q2, with $100M more expected. The trajectory shows delivery on portfolio growth and revenue expansion.
Complete the transition of Avamere properties to new operators and optimize portfolio cash NOI through re-tenanting and lease amendments.
Stated in 2 disclosures including July 2026 update and 2026-Q2. Management plans to transition all 26 Avamere properties, increasing annualized cash rent from $41M in 2025 to $53M. The rent reset to $48M was executed in 2026-Q2. The trajectory shows active execution and portfolio optimization progress.
“Sabra exercised its option to reset the rent under its lease with Avamere to a fixed amount tied to the portfolio's historical performance, increasing annualized fixed cash rent to $48 million.”
Lower behavioral health portfolio concentration and overall leverage by repaying $200 million of RCA mortgage early.
Newly stated in July 2026. Management completed a $200 million repayment of the $300 million RCA mortgage, reducing behavioral health concentration from 13% to 9% and lowering leverage. This transaction reflects a strategic capital allocation shift and balance sheet strengthening.
Over the trailing year it converted 2.49x of net income into operating cash flow. Historically, Real Estate names rated neutral grew net income 57% of the time over the next year (vs 46% for the rest of the cohort, n=2946).
Not enough signal yet.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, long-term interest rates, the broad stock market, Fed net liquidity (low R² over the window).
8 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Real Estate names rated stable grew net income 43% of the time over the next year (vs 55% for the rest of the cohort, n=685).
Not investment advice. As of 2026-09-04.
“On April 29, 2026, Sabra's Board of Directors declared a quarterly cash dividend of $0.30 per share.”
“On February 2, 2026, Sabra's Board of Directors declared a quarterly cash dividend of $0.30 per share.”
“On November 5, 2025, Sabra's Board of Directors declared a quarterly cash dividend of $0.30 per share.”
“On August 4, 2025, Sabra's Board of Directors declared a quarterly cash dividend of $0.30 per share.”
“Sabra has now closed on approximately $600 million in investments this year, with another $100 million in the process of closing.”
“Sabra acquired three managed senior housing properties and one skilled nursing facility for $102 million with an average initial cash yield of 8.3%.”
“Sabra acquired four managed senior housing properties for $150.5 million with an estimated initial cash yield of 7.0%, bringing total investments closed in 2025 to roughly $450 million.”